Impact of ischemic stroke topography on early clinical outcome of basilar artery occlusion: a retrospective study
- Open Access
- 25.04.2024
- Neuro
Abstract
Introduction
Materials and methods
Study population
Ethical approval
Clinical parameters
Grading of occlusion site, basilar stenosis, and infarct
Statistical analysis
Results
Baseline characteristics, clinical, and angiographic outcomes
All | BAOS | BAOE | p | All | Proximal occlusion | Middle occlusion | Distal occlusion | p | |
|---|---|---|---|---|---|---|---|---|---|
n | 196 | 57 (29.1%) | 139 (70.9%) | 199 | 53 (26.6%) | 54 (27.1%) | 92 (46.2%) | ||
Missing | 3 | 0 | |||||||
Baseline and procedural characteristics | |||||||||
Age, years, median (IQR) | 75 (63–82) | 72 (61.5–79) | 76 (63–82) | 0.155 | 75 (63–82) | 72 (60–79) | 74 (59–82) | 78 (68.4–83) | 0.026 |
Male sex, n, (%) | 112 (57.1%) | 37 (64.9%) | 75 (54.0%) | 0.204 | 115 (57.8%) | 34 (64.2%) | 28 (51.9%) | 53 (57.6%) | 0.436 |
mTICI | |||||||||
0–2a, n, (%) | 14 (7.3%) | 9 (16.1%) | 5 (3.7%) | 17 (8.5%) | 7 (13.5%) | 6 (11.3%) | 4 (4.4%) | ||
2b, n, (%) | 47 (24.5%) | 15 (26.8%) | 32 (23.5%) | 0–2a vs. 2b/3: 0.005 | 47 (23.6%) | 9 (17.3%) | 17 (32.1%) | 21 (23.3%) | 0–2a vs. 2b/3: 0.136 |
3, n, (%) | 131 (68.2%) | 32 (57.1%) | 99 (72.8%) | 0.041 | 131 (65.8%) | 36 (69.2%) | 30 (56.6%) | 65 (72.2%) | 0.154 |
Procedure time (min, median/IQR) | 60 (31–104) | 101.5 (55.5–140) | 45 (26.75–85) | 0.000 | 60 (31–104) | 85 (49–135) | 69 (35–118) | 45 (25–73) | 0.000 |
Onset to groin time (min, median/IQR) | 270 (195–390) | 305 (224.25–480) | 260 (182.5–360) | 0.074 | 270 (195–390) | 300 (240–415) | 261 (181.25–372.5) | 252 (185.25–390) | 0.223 |
No. of passes (median/IQR) | 2 (1–3) | 2 (1–3) | 2 (1–3) | 0.108 | 2 (1–3) | 2 (1–3) | 2 (1–3) | 1 (1–2) | 0.073 |
Success of aspiration only, n (%) | 56 (29.0%) | 6 (10.5%) | 50 (36.8%) | 0.000 | 56 (28.1%) | 8 (15.1%) | 19 (35.8%) | 29 (32.6%) | 0.034 |
Preinterventional intravenous tPA, n (%) | 77 (39.3%) | 19 (33.3%) | 58 (41.7%) | 0.334 | 77 (38.7%) | 20 (37.7%) | 19 (35.2%) | 38 (41.3%) | 0.754 |
BA stent implantation, n (%) | NA | 45 (78.9%) | NA | NA | NA | NA | NA | NA | NA |
Pre-treatment NIHSS, median (IQR) | 13 (6.75–22) | 14 (7–22.75) | 13 (7–22) | 0.630 | 13 (6.75–22) | 16 (7–24) | 13 (7–22) | 12 (6–20.25) | 0.436 |
Outcome | |||||||||
Post-treatment NIHSS, median (IQR) | 10 (2.75–42) | 15 (8–42) | 6 (2–20) | 0.001 | 10 (2.75–42) | 12.5 (6.5–42) | 11 (3–42) | 5 (1–18.5) | 0.017 |
Substantial neurological improvement, n (%) | 63 (34.4%) | 14 (25.9%) | 49 (38.0%) | 0.128 | 63 (31.7%) | 16 (32%) | 12 (23.5%) | 35 (41.2%) | 0.103 |
NIHSS Improvement, median (IQR) | 2 (−2.0–8.75) | 1 (−24.0–6.5) | 3 (0.0–10.0) | 0.007 | 2 (−2.0–8.0) | 1.5 (−18.0–8.75) | 1 (−2.0–6.0) | 3 (0.0–10.0) | 0.463 |
mRS post-treatment (n = 190) | 4 (2–5.25) | 5 (4–6) | 4 (2–5) | 0.001 | 4 (2–5.25) | 5 (4–6) | 4.5 (3–5.75) | 4 (1–5) | 0.008 |
mRS 0–3 (early good clinical outcome), n (%) | 70 (37.4%) | 10 (18.2%) | 60 (45.5%) | 0.000 | 71 (35.7%) | 11 (21.2%) | 18 (34.6%) | 42 (48.8%) | 0.004 |
mRS > 3, n (%) | 117 (62.6%) | 45 (81.8%) | 72 (54.5%) | 119 (59.8%) | 41 (78.8%) | 34 (65.4%) | 44 (51.2%) | ||
mRS after 3 months, median (IQR) (n = 83) | 4 (1–6) | 4 (1–6) | 3 (1–6) | 0.234 | 4 (1–6) | 4 (3–6) | 4 (1–6) | 2.5 (1–6) | 0.345 |
Effect of BS and occlusion location on ischemic territory
Impact of ischemic pattern on early clinical outcome
Impact of baseline data on early clinical outcome
Regression coefficient β | p | Odds ratio (95% CI) | |
|---|---|---|---|
Occlusion location (BA thirds) | 0.619 | 0.009 | 1.856 (1.165–2.958) |
Procedure time | ‒0.011 | 0.008 | 0.981 (0.981–0.997) |
Age | ‒0.039 | 0.005 | 0.962 (0.936–0.988) |
Diabetes | ‒2.069 | 0.002 | 0.126 (0.035–0.454) |
Role of ischemic pattern for outcome in BAO with BS
Discussion
Functional eloquence of brain stem tissue
Worse angiographic outcome in patients with basilar stenosis
Implications
Limitations
Conclusion
Supplementary information
Compliance with ethical standards
Guarantor
Conflict of interest
Statistics and biometry
Informed consent
Ethical approval
Study subjects or cohorts overlap
Methodology
-
Retrospective
-
Observational
-
Single center study